PTGX Protagonist Therapeutics Inc

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.

$42.94  -0.33 (-0.76%)
As of 06/24/2021 15:59:33 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/11/2016
Outstanding shares:  43,945,166
Average volume:  573,806
Market cap:   $1,907,220,204
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    74366E102
ISIN:        US74366E1029
Sedol:      BDCBCD8
Valuation   (See tab for details)
PE ratio:   -27.14
PB ratio:   7.33
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy